Objective: To evaluate the pathologic significance of immunoglobulin G4 (IgG4) in patients with inflammatory peripheral neuropathy.
METHODS Patients. We retrospectively investigated 149 consecutive patients who were referred for diagnostic sural nerve biopsy to the pathologic department of our institution from January 1997 to July 2014 and who had clusters of inflammatory cells in formalin-fixed paraffin-embedded sural nerve biopsy specimens either with or without vasculitis. We included patients in whom we were able to assess the serum level of IgG4. As shown in table 1, we tentatively classified the 149 patients included in this study according to the existing nomenclature or diagnostic criteria including the 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitis (CHCC2012). 9 The patients were classified as follows: microscopic polyangiitis (MPA) in 53 patients; eosinophilic granulomatosis with polyangiitis (EGPA), or Churg-Strauss syndrome (CSS), in 24 patients; granulomatosis with polyangiitis (GPA), or Wegener granulomatosis (WG), in 1 patient; polyarteritis nodosa in 1 patient; and hypocomplementemic urticarial vasculitis in 1 patient. Thirteen other patients were classified as nonsystemic vasculitic neuropathy according to the diagnostic criteria of the Peripheral Nerve Society Guideline of Non-systemic Vasculitic Neuropathy. 10 These 93 patients were separated into a group of patients with neuropathy due to primary vasculitis. Vasculitis was defined as fulfilling definite or probable pathologic criteria based on a previous report. 10 An additional 30 patients were considered to have inflammatory cell infiltration or vasculitis secondary to underlying disease. The remaining 26 patients had inflammatory cellular infiltration in sural nerve biopsy specimens but did not have vasculitis or an underlying disease; thus, these patients were separated into a group of patients with neuropathy of undetermined etiology. Patients exhibiting direct invasion of malignant neoplasms, such as those with neurolymphomatosis, were excluded.
Recently, comprehensive diagnostic criteria for IgG4-RD were published for the diagnosis of various organ involvements and for practical use by general physicians and nonspecialists. 11 The threshold levels of the serum IgG4 and the extent of IgG4positive plasma cells in this study were based on these criteria. Serum IgG4 concentrations were determined by a nephelometry assay (SRL, Inc., Tokyo, Japan). Patients with serum IgG4 concentrations $135 mg/dL were included. For histopathologic examination, we adopted the following criteria of marked infiltration of lymphocytes and plasmacytes accompanied by IgG41 plasma cells: ratio of IgG41/IgG1 cells .40% and .10 IgG41 plasma cells/high power field (3400). In addition to organ involvement and damage, the comprehensive diagnostic criteria for IgG4-RD 11 define patients who fulfill both serum and pathologic criteria to be definite. Patients meeting only pathologic criterion are diagnosed as probable, and those with only serologic criterion are classified as possible.
All patients underwent clinical and neurologic assessments, routine blood and urine examinations, nerve conduction studies, and sural nerve biopsies. A nerve conduction study was performed on all patients as previously described according to a standard method using surface electrodes for stimulation and recording. 12 Motor conduction was investigated in the median, ulnar, and tibial nerves, and sensory conduction was investigated in the median, ulnar, and sural nerves. The amplitudes of the compound muscle action potentials and sensory nerve action potentials were measured from the baseline to the first negative peak. The control values were based on a previous report. 12 Standard protocol approvals, registrations, and patient consents. This study was approved by the ethics committees of Nagoya University Graduate School of Medicine, and all patients provided written informed consent.
Pathologic examinations of the sural nerve biopsy specimens. Histopathologic examinations of the sural nerve were performed on all patients under local anesthesia. 13, 14 The specimens were divided into 2 portions. The first portion was fixed in 2.5% glutaraldehyde in 0.125 M cacodylate buffer (pH 7.4) and embedded in epoxy resin for morphometric examination. The density of myelinated fibers was assessed in toluidine blue-stained semi-thin sections using a computer-assisted image analyzer (Luzex FS; Nikon, Tokyo, Japan), and the density of myelinated fibers was calculated as previously described. 15 A fraction of the glutaraldehyde-fixed sample was processed for a teased-fiber study, and the pathologic status was microscopically assessed according to previously described criteria. 12 The second portion of the specimen was fixed in 10% formalin solution and embedded in paraffin. Sections were sliced using routine methods and then stained with hematoxylin & eosin and the Masson Abbreviation: IgG4 5 immunoglobulin G4.
trichrome method. A 10-mm-long longitudinal section and an entire transverse section were examined to assess cellular infiltration for each case.
To evaluate the infiltration of IgG-positive cells and IgG4positive plasma cells, immunohistochemistry was performed on deparaffinized sections via an immunoperoxidase staining technique using the following antibodies: mouse anti-human IgG (Histofine, Tokyo, Japan) and sheep anti-human IgG4 (The Binding Site Group Limited, Birmingham, UK). The degree of IgG4-positive cell infiltration into the sural nerve biopsy specimens was categorically graded in one transverse section and one longitudinal section as follows: 0 for no IgG4-positive cells, 1 for 1-50 IgG4-positive cells, or 2 for greater than 50 IgG4positive cells. To determine the extent of fibrosis, we measured the percentage of the connective tissue area in cross-sections stained with hematoxylin & eosin (figure 1). First, we selected the entire area of the hematoxylin & eosin-stained sural nerve cross-sections ( figure 1A) and manually subtracted the area of the nerve fascicules and the vessel lumens using ImageJ software version 1.46r ( figure 1B ). Second, we extracted the connective tissue area (figure 1C) and the entire imaged area of the epineurium ( figure 1D ). Finally, the image software automatically calculated the percentage of the connective tissue area relative to the entire imaged area of the epineurium without the area of the nerve fascicules and the vessel lumens. Control values were obtained from 13 autopsy cases in which patients had died of nonneurologic diseases (48.5 6 23.5 years of age; male:female, 7:6).
Statistical analyses. Quantitative data are presented as mean 6 SD. Student t tests were used for the parametric variables. Mann-Whitney U tests were used for the nonparametric variables. (table 1) .
Pathologically, 29 patients had IgG4-positive cell infiltration that fulfilled the histopathologic criteria for IgG4-RD (table 1). 11 IgG4-positive cell infiltration was observed in 11 of 53 patients (21%) with MPA, 11 of 24 patients (46%) with EGPA/CSS, 1 of 10 patients (10%) with Sjögren syndrome, 1 of 8 patients (13%) with rheumatoid arthritis, 1 of 1 patient with hypocomplementemic urticarial vasculitis, 1 of 1 patient with hepatitis B virus-associated vasculitis, and 3 of 26 patients (12%) with undetermined etiology (table 1) .
Considering both the serologic and the histopathologic findings, 44 patients fulfilled either the serologic or the pathologic criterion for IgG4-RD. The patients who exhibited elevated serum IgG4 levels or IgG4-positive cell infiltration included 24 men and 20 women (table e-1 on the Neurology ® Web site at Neurology.org). The age at onset of neuropathy ranged from 37 to 86 years (64.5 6 10.6). The mode of progression was acute to subacute in most patients. The initial symptoms of neuropathy were numbness or pain in the distal portions of the extremities, typically in the lower leg. Most patients exhibited a pattern of multiple mononeuropathy accompanied by sensory and motor disturbances. Autonomic involvement in orthostatic symptoms, digestive symptoms, urinary symptoms, pupillary reaction, sicca symptoms, or perspiration was not conspicuous in any case. Thirty-two patients (73%) exhibited leukocytosis in their peripheral blood. Abnormalities of C-reactive protein levels and erythrocyte sedimentation rates were observed in 36 patients (82%) and 35 patients (80%), respectively. Elevation of the serum IgG levels was observed in 27 patients (61%). The antineutrophil cytoplasmic antibody (ANCA) test revealed myeloperoxidase ANCA positivity in 32 of 53 patients (60%) previously diagnosed with MPA and in 5 of 24 patients (21%) previously diagnosed with EGPA/CSS. Proteinase 3 ANCA positivity was observed in 4 patients with MPA and in 1 patient with EGPA/CSS. CSF analysis revealed slightly increased cell counts in 1 patient (2%) and slightly elevated protein levels in 8 patients (18%).
Nerve conduction study results indicated axonal neuropathy in all patients. A reduction in compound muscle action potentials and sensory nerve action potentials was frequently observed in the lower extremities. Compound muscle action potentials were not evoked in the median, ulnar, or tibial nerve in 7%, 7%, and 27% of the patients, respectively. Sensory nerve action potentials were not evoked in the median, ulnar, or tibial nerve in 23%, 20%, and 77% of the patients, respectively.
Pathologic features. The sural nerve biopsy specimens exhibited reductions in the density of both large and small myelinated fibers (686 6 823 and 1,406 6 1,256 fibers/mm 2 for large and small myelinated fibers, respectively; control values, 3,258 6 736 and 5,302 6 655 fibers/mm 2 , respectively). The frequency of axonal degeneration ranged from 2.8% to 100% (66.3% 6 34.2%; control, 1.6% 6 1.8%); alternatively, segmental remyelination and demyelination was uncommon (3.2% 6 6.8%; control, 6.9% 6 6.5%).
In the 44 patients with elevated serum IgG4 levels or IgG4-positive cell infiltration, findings suggestive of the destruction or obstruction of the vessel walls were observed in 34 (77%) patients (including 12 patients with MPA and 16 patients with EGPA/CSS). Sixteen (36%) of these patients (including 9 patients with MPA and 5 patients with EGPA/CSS) exhibited fibrinoid necrosis of the vessel walls. Inflammatory between the serum IgG4 levels and the extent of fibrosis was less strong (r 5 0.198, p , 0.05). Little to no correlation was observed between other pathologic parameters and the serum IgG4 levels or the grade of IgG4-positive cell infiltration. The age at biopsy and the duration of neuropathy did not correlate with the extent of epineurial fibrosis.
DISCUSSION IgG4-RD has been reported to affect various organs, and organ-specific diagnostic criteria have been established for IgG4-related autoimmune pancreatitis, IgG4-related Mikulicz disease, and IgG4-related kidney disease. 11 Through the analysis of 149 patients, we found 44 patients with significant serum IgG4 level elevation or IgG4-positive cell infiltration as defined by the comprehensive diagnostic criteria for IgG4-RD. 11 According to the comprehensive diagnostic criteria for IgG4-RD, it is important to differentiate IgG4-RD from similar diseases such as Sjögren syndrome, GPA/WG, EGPA/CSS, and sarcoidosis. Even after the exclusion of these diagnoses, 23 of 44 patients remained in our study. The data excluding patients with diseases considered to be differential diagnoses in the comprehensive diagnostic criteria for IgG4-RD were similar to the data including patients with these diseases (table e-1).
As the current comprehensive diagnostic criteria for IgG4-related disease recommended, in our study, we regarded pathologic findings as more important than serum IgG4 levels. 11 Therefore, we selected patients with inflammatory cellular infiltration and determined whether IgG4-positive plasma cells were present and assessed the serum IgG4 levels in these patients. In the same study period, we had 624 patients without inflammatory cellular infiltration on sural nerve biopsy specimens in whom we were able to assess the serum IgG4 levels. These patients were suspected of having inflammatory neuropathies because patients with noninflammatory diseases, such as diseases of nutritional, metabolic, and hereditary etiologies, were excluded. Of these patients, 49 had serum IgG4 levels $135 mg/dL, most of whom were considered as having diseases listed as differential diagnoses of IgG4-RD. 11 The frequency of patients with IgG4 levels $135 mg/dL was higher in the group with inflammatory cellular infiltration than that without (p , 0.01). IgG4 antibodies that react with contactin-1 have been described in a subset of patients with chronic inflammatory demyelinating polyneuropathy (CIDP). 16, 17 Of the 773 patients whose serum IgG4 levels were assessed in the present study (149 with cellular infiltration and 624 without), 129 patients were considered as having CIDP meeting the definite or probable criteria raised by the European Federation of Neurological Societies/ Peripheral Nerve Society. 18 Two of these patients (without cellular infiltration) had IgG4 levels $135 mg/dL.
From the perspective of neuropathy, inflammatory cell infiltration is observed in numerous settings. 10, 19, 20 In this study, IgG4-positive plasma cell infiltration that fulfilled the histopathologic criteria of IgG4-RD was observed in 29 patients. Among these Figure 4 Comparisons and correlations of fibrosis in the epineurium (n 5 149)
Patients with elevated serum immunoglobulin G4 (IgG4) levels or IgG4-positive cell infiltration who fulfilled histopathologic criteria for IgG4-related disease had more severe fibrosis than patients without these characteristics or normal controls (A). Although there was a significant association between the serum IgG4 values and fibrosis (p , 0.05) (B), there was little correlation between these factors. The grade of IgG4-positive cell infiltration correlated with fibrosis (p , 0.01) (C).
patients, 22 met the definitions for MPA and EGPA/ CSS as described in the CHCC2012. 9 According to the CHCC2012, these small vessel vasculitides are subcategorized into ANCA-associated vasculitis, which includes the following 3 disease categories: MPA, EGPA/CSS, and GPA/WG. In these diseases, the frequency of concomitant peripheral neuropathy is particularly high for MPA and EGPA/CSS. 21 EGPA/CSS and GPA/WG have been reported to be similar to IgG4-RD, as serum IgG4 elevation and IgG4-positive cell infiltration are typically observed in these diseases. 6, [22] [23] [24] [25] [26] [27] [28] [29] [30] Therefore, EGPA/ CSS and GPA/WG patients were excluded from an IgG4-RD diagnosis based on the exclusion criteria of the comprehensive diagnostic criteria for IgG4-RD. 11 The association of MPA with the IgG4 status has yet to be determined, and MPA does not fit exclusion criteria of the comprehensive diagnostic criteria for IgG4-RD. 11 In this study, 23% of the patients with MPA had elevated serum IgG4 levels or IgG4positive cellular infiltration. Subgroup analyses of the patients previously diagnosed with MPA revealed similar findings to the analyses of all of the patients: the extent of epineurial fibrosis correlated with the grade of IgG4-positive cell infiltration (r 5 0.495, p , 0.01) (table e-2 and figure e-1). Therefore, we suggest a reconsideration of the criteria according to the relation of nosologic entities of these diseases to IgG4-RD. Furthermore, recent studies have reported the similarity of rheumatoid arthritis and hypocomplementemic urticarial vasculitis to IgG4-RD. 28, 31, 32 In patients with IgG4-RD, abnormalities of vessels, such as obliterative phlebitis, are common pathologic findings in several organs, including the pancreas, the bile duct, the retroperitoneal tissue, and the aorta. 1,2 IgG4-positive plasma cells can infiltrate the media or adventitia of arteries in medium and large vessels of the aorta, the femoral artery, the popliteal artery, and the coronal artery, as has been reported in IgG4-RD. [33] [34] [35] [36] [37] [38] [39] [40] This inflammatory cell infiltration causes the formation of aneurysms. In this report, pathologic findings of vasculitis were frequently observed. In fact, most of the patients with such vasculitis were categorized as having EGPA/CSS or MPA based on the current nomenclature. 9 This is a peculiar feature of peripheral neuropathy from the perspective of IgG4-RD, as disturbances of the arteries typically involve non-necrotizing lymphoplasmacytic infiltration with or without the obliteration of the lumen, according to the consensus statement on IgG4-RD. 8 However, IgG4-positive cell infiltration correlated with fibrosis in the epineurium in the present study, even in patients previously diagnosed with MPA. Therefore, IgG4-positive cell infiltration may participate in the mechanisms underlying the pathogenesis of neuropathy via the exacerbation of fibrosis.
Several of the patients exhibited significant epineurial fibrosis although their duration of neuropathy was short. Hence, it may be hypothesized that several smoldering disease processes affect the peripheral nervous system before neuropathic symptoms become evident. Future studies are necessary to elucidate the significance of IgG4 in peripheral neuropathy.
